Mikael Oerum, Chairman

Mikael is Founder and Partner of Ventac Partners and has 40 years of executive experience in finance and biotech. He is currently CEO and Chairman (and co-founder) of Avexxin AS, Co-founder and Board Member of Idogen AB, which listed on Swedish Aktietorget in 2015, and Chairman of RhoVac AB, which listed on Swedish Aktietorget in 2016. He has raised $100Mio in risk capital for biotech and pharma ventures. He has been responsible for multiple licensing deals in USA, Europe, Japan and China. He was co-founder and CEO of Exiqon, which was listed on Nasdaz OMX in 2007 from 1995-2002. He was co-founder of Santaris Pharma which sold to Hoffman la-Roche in 2014 for $450 Mio. Mikael has business and legal educations from Copenhagen Business College, Danish Bankers Academy, Copenhagen Business School and Copenhagen University.

Dede Willis, Executive Board Member

Harold “Skip” Garner, Executive Board Member